Nebraska voters will decide this Election Day on a pair of citizen-initiated ballot measures regulating medical cannabis access to authorized patients.
State regulators last week affirmed that advocates Nebraskans for Medical Marijuana had gathered the requisite number of signatures to place the measures before voters.
The two measures are complementary. The first permits qualified patients to possess and use cannabis. The second measure regulates the production and distribution of cannabis to those authorized patients. Advocates had to frame the issue as two separate ballot questions in order to not run afoul of the state’s ‘single subject’ rule. In 2020, the state Supreme Court invalidated a similar stand-alone measure for addressing issues that it deemed were “not naturally and necessarily connected to the [initiative’s] primary purpose.” A 2022 effort failed to obtain sufficient signatures to qualify for the ballot.
“States have a proven track record of safely and effectively regulating medical marijuana,” NORML’s Deputy Director Paul Armentano said. “After November, Nebraskans will no longer be forced to choose between their medicine or their freedom.”
Thirty-eight states, the District of Columbia, and several US territories regulate medical cannabis products. Statewide polling indicates that between 70 percent and 80 percent of Nebraskans support legalizing medical marijuana access.
Nebraska is one of at least four states where cannabis-related initiatives will appear on November’s ballot. Voters in Florida, North Dakota, and South Dakota, who also will be deciding on adult-use legalization measures this fall.
In Texas, voters in the cities of Bastrop (population 11,200), Dallas (population: 1.3 million), and Lockhart (population 15,000) will decide on municipal ballot measures prohibiting local law enforcement from making low-level marijuana-related arrests.
I’m a Registered Dietitian and Holistic Cannabis Practitioner, and it is my mission to teach you how to harness the power of the cannabis plant to naturally manage the stress of every day life so you can bring back joy, build better relationships, and live a better quality of life.
Cannabis changed my life, and it can change yours, too.
Take 1-2 gummies at a time, depending on your tolerance level
Adjust your serving size as needed
Take 30 minutes before bed, depending on your needs
Wide-mouth jars with child-resistant lids
Keep out of reach of children
Individual results may vary
Ingredients
Organic cane sugar, distilled water, organic tapioca syrup, fruit pectin, organic vanilla, and chamomile flavor extract, citric acid, potassium citrate, fruit & vegetable extracts for color, and natural terpenes.
DESCRIPTION
These vanilla chamomile sleep gummies aren’t just any ordinary gummies.
They’re specially crafted with your peaceful slumber in mind, designed to help you fall asleep faster and stay asleep longer.
Each Sleepy Bliss Gummy is infused with a powerful blend of 5mg ∆9-THC, 5mg CBN, and 5mg CBD. This trio works harmoniously to lull you into a state of deep relaxation, preparing your body and mind for a night of restorative sleep.
We’ve made sure that dosing is as simple as possible. No more complicated measurements or guesswork. With our simplified dosing, you can easily take your daily serving and enjoy the benefits of these gummies without any hassle.
These Sleepy Bliss Gummies contain a blend of various Indica strains, making them perfect for winding down after a long day or enjoying a restful weekend.
Whether you’re winding down after a long day or looking for a relaxing way to spend your weekend, Sleepy Bliss Gummies are your go-to choice.
And the best part? NO groggy, foggy, or hungover feeling in the morning!
A Safe & Legal Option
Many ask, “How can these gummies contain 5mg of THC and be less than 0.3% THC?” 🤔
The answer is found in math. Each gummy weighs 5 grams or 5,000 milligrams. And 0.3% of 5,000 = 15 milligrams. That means this product is under the legal limit.
Therefore, these gummies contain less than 0.3% Δ9-THC by weight of each teaspoon, making them Federally legal under the 2018 Farm Bill.
And yes, these gummies are exclusively made with delta-9 THC; we do not sell or support delta-8 THC products at this time.
We absolutely understand your hesitation in ordering cannabis online.
Even with the increasing acceptance of cannabis, plenty of challenges still come with it, making it understandable if you feel uncertain. We assure you this purchase is legal and worth every penny.
Lab Testing
Independent, third-party lab testing ensures that only the highest quality product is delivered to you. Our lab test results are produced by SC Labs, formerly Botanacor Laboratories. Each product is thoroughly tested to ensure purity, potency, and effect. Free from microbial contaminants, heavy metals, and residual solvents – quality is our standard! You can cross-check our promise by reviewing the lab test in the image gallery of each product.
The Highest Quality
All Emily Kyle products are processed in Denver, Colorado, by VivaOil, LLC. Our products are proudly made in the USA in a third-party tested, cGMP, FDA-registered & certified facility.
Our products are formulated with more than just THC and CBD. We include minor cannabinoids and a blend of terpenes known to enhance wellness. Through gentle CO2 extraction, we capture the whole plant with a range of cannabinoids and terpenes. These compounds work together synergistically to enhance results. Beyond taste and flavor, they provide a wealth of potential health benefits. Terpenes and minor cannabinoids are essential ingredients to a true full-spectrum experience.
Shipping Options
We ship packages with the United States Postal Services (USPS). All shipments are legal based on their hemp-based product requirements. Your package will arrive in an unmarked box or envelope for discrete arrival. Unfortunately, current laws prevent us from shipping to any country outside of the US at this time.
These statements have not been evaluated by the FDA. This product is not intended to diagnose, treat, cure, or prevent any disease. This product should be used only as directed on the label. It should not be used if you are pregnant or nursing. Consult a physician before use if you have a serious medical condition or use prescription medications. A Doctor’s advice should be sought before using this and any supplemental product. By using this site, you agree to follow the Privacy Policy and all Terms & Conditions printed on this site. Void where Prohibited by Law. Our products contain less than 0.3% THC.
Republican Gov. Chris Sununu has signed a pair of bills into law expanding patients’ ability to access medical cannabis products.
The first bill, SB 357, expands the pool of health care professionals who can recommend medical cannabis to include anyone “who is licensed to prescribe drugs to humans and who possesses an active registration from the United States Drug Enforcement Administration to prescribe controlled substances and who is primarily responsible for the patient’s care related to his or her qualifying medical condition.”
The second bill, HB 1278, provides discretion to health care providers to issue medical cannabis recommendations to any patient who may benefit from it — regardless of whether or not they suffer from a state-specific qualifying condition. Under the newly expanded law, which takes effect in 60 days, physicians may recommend cannabis in any instance where they believe that “the potential benefits of using therapeutic cannabis would, in the provider’s clinical opinion, likely outweigh the potential health risks for the patient.”
NORML’s Deputy Director Paul Armentano praised the bill’s passage. “Physicians already possess the discretion to prescribe any number of medications, like opioids, which pose far greater risks to health than marijuana. It is appropriate that health care providers possess the same freedom to make medical cannabis-related decisions as they do when choosing to authorize other therapeutic options for their patients.”
Similar legislation was approved earlier this year in Delaware. Several other states, including California, Maine, and Virginia, provides physicians with similar discretion.
Over 13,000 New Hampshire residents are currently enrolled in the state’s medical cannabis access program.
